Scopus BioPharma (NASDAQ: SCPS)
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-12-20 | ||||||
REV |
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-11-09 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Scopus BioPharma (NASDAQ: SCPS) through any online brokerage.
Other companies in Scopus BioPharma’s space includes: PolarityTE (NASDAQ:PTE), Exicure (NASDAQ:XCUR), Benitec Biopharma (NASDAQ:BNTC), Addex Therapeutics (NASDAQ:ADXN) and Histogen (NASDAQ:HSTO).
The latest price target for Scopus BioPharma (NASDAQ: SCPS) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting SCPS to rise to within 12 months (a possible 788.89% upside). 50 analyst firms have reported ratings in the last year.
The stock price for Scopus BioPharma (NASDAQ: SCPS) is $0.45 last updated August 12, 2022, 8:00 PM UTC.
The next Scopus BioPharma (SCPS) dividend date is projected to be Thursday, September 1, 2022.
Scopus BioPharma’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Scopus BioPharma.
Scopus BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.